JEOL
JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) announces the release of a new Schottky field emission scanning electron microscope, JSM-IT800 in May 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200524005002/en/
Development Background
Scanning electron microscopes (SEMs) are used in various fields, such as nanotechnology, metals, semiconductors, ceramics, medicine, and biology. As SEM applications are expanding from research and development to quality control and product inspection at manufacturing sites, SEM users are in need of faster high-quality data acquisition and simple compositional information confirmation with seamless operation.
To meet these demands, the JSM-IT800, with the Intelligence Technology (IT) platform, incorporates our In-lens Schottky Plus field emission electron gun for high resolution imaging to fast elemental mapping, and an innovative electron optical control system "Neo Engine", as well as a seamless GUI "SEM Center" for full integration of a JEOL energy dispersive X-ray spectrometer (EDS). Furthermore, the JSM-IT800 offers two versions with two types of objective lens: the Hybrid Lens (HL) for general-purpose SEM and the Super Hybrid Lens (SHL) for enhanced resolution observation and various analyses.
Moreover, the SHL version comes with a new Upper Hybrid Detector (UHD) realizing higher signal-to-noise ratio images.
A new Scintillator Backscattered Electron Detector (SBED) and a Versatile Backscattered Electron Detector (VBED) are also available with the JSM-IT800.
Features
1. In-lens Schottky Plus field emission electron gun
Enhanced integration of the electron gun and low-aberration condenser lens provides higher brightness. Ample probe current is available at low accelerating voltage (100 nA at 5 kV). The unique In-lens Schottky Plus system enables various applications from high resolution imaging to fast elemental mapping, electron backscatter diffraction (EBSD) analysis, and soft X-ray emission spectroscopy (SXES), without the requirement to change lens conditions.
2. Neo Engine (New Electron Optical Engine)
Neo Engine is a cutting-edge electron optical system that accumulates JEOL core technologies of many years. Users can perform stable observation even when changing observation or analytical conditions. High operability for automatic functions is further enhanced.
3. SEM Center / EDS Integration
A GUI "SEM Center" is fully integrated as well as JEOL EDS for seamless and intuitive operations. The JSM-IT800 can be enhanced by incorporating optional software add-ons, such as SMILENAVI to assist novice users and the LIVE-AI filter (Live Image Visual Enhancer – AI) for a higher quality of live images.
4. Hybrid Lens (HL) version and Super Hybrid Lens (SHL) version
Based on a combination of the electrostatic and electromagnetic-field lens, two types of objective lens versions are available to satisfy various needs of users, achieving high spatial resolution imaging and analysis of a broad range of samples, from magnetic materials to insulators, with the features of the JSM-IT800.
5. Upper Hybrid Detector (UHD)
The UHD, built into the objective lens for the SHL version, greatly improves detection efficiency, leading to acquisition of images with a higher signal-to-noise ratio.
6. New Backscattered Electron Detectors
The Scintillator Backscattered Electron Detector (SBED, optional) has high responsiveness and is suitable to acquire material-contrast images at low accelerating voltage. The Versatile Backscattered Electron Detector (VBED, optional) with a segmented detector element design, allows the user for the choice to configure the individual segments or use preprogrammed detector settings to acquire images with three-dimensional, topographical, or compositional information.
Sales target
1) JSM-IT800 SHL version: 90 units/year
2) JSM-IT800 HL version: 50 units/year
JEOL Ltd.
3-1-2, Musashino, Akishima, Tokyo, 196-8558, Japan
Izumi Oi, President & COO
(Stock code: 6951, Tokyo Stock Exchange First Section)
www.jeol.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200524005002/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members22.10.2025 14:00:00 CEST | Press release
Coverage effective across Elevance Health’s commercial, Medicare, and Medicaid plans in 14 states Decision informed by growing clinical evidence, with additional real-world and long-term safety and efficacy data now being collected across global centers HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced that Elevance Health (formerly Anthem, Inc.) has issued a positive medical policy for the use of histotripsy in the treatment of liver tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022130560/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics The policy, effective October 21, 2025, expands insurance coverage across Elevance Health’s commercial, Medicare, and Medicaid plans in 14 states, including California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virgin
Regula Launches Knowledge Hub to Advance Understanding of Digital ID22.10.2025 14:00:00 CEST | Press release
Regula, a leading developer of identity verification (IDV) solutions and forensic devices, has unveiled a new online resource center, The Road to Digital ID. This knowledge hub is designed to provide a clear, structured guide to what digital identity is, how it’s verified, what risks it brings, and what opportunities it creates. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022763979/en/ Regula’s knowledge hub, The Road to Digital ID, comprises educational content, research findings, tech know-how, and general-interest articles. Across the world, governments and businesses are increasingly embracing digital identity frameworks. In the UK, for example, the government recently announced a new digital ID scheme that will be mandatory for Right to Work checks. While hailed as a modernization effort, it has also reawakened debates about privacy, trust, and governance. Digital ID nailed down Although nearly half of organizatio
AI and Data Leaders NVIDIA, AMD, Snowflake, and Databricks Invest in Uniphore’s Series F to Accelerate Its Leadership in Business AI22.10.2025 13:30:00 CEST | Press release
Uniphore, the Business AI company, today announced the close of its $260 million Series F round. NVIDIA, AMD, Snowflake, and Databricks invested in the round and were joined by financial and sovereign investors including NEA, March Capital, BNF Capital, National Grid Partners, and Prosperity7 Ventures. The new capital will accelerate innovation on its AI and data platform – Business AI Cloud – while deepening its ecosystem. “Our Series F raise marks an exciting milestone for Uniphore. It is unlike most fundraises because, in addition to top-tier financial investors, we are joined by the world’s top AI and data companies,” said Umesh Sachdev, Co-founder and CEO, Uniphore. “This unique combination of capital and strategic alignment validates Uniphore’s position as the Business AI leader. We are seeing exponential adoption from Fortune 500 and other large companies, and this investment allows us to deliver even greater impact and accelerate innovation on behalf of our customers worldwide.
BeOne Medicines to Announce Third Quarter 2025 Financial Results on November 622.10.2025 12:01:00 CEST | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its third quarter 2025 financial results on Thursday, November 6, 2025 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting developme
Diligent and Persefoni Form Strategic Partnership to Support Clients in Navigating Sustainability Reporting With Confidence22.10.2025 12:00:00 CEST | Press release
Diligent, the AI leader in governance, risk and compliance SaaS solutions, and Persefoni AI, Inc., a leading Sustainability Management SaaS and AI platform for companies and financial institutions, today announced a strategic partnership to lead the way in sustainability by ensuring clients have the best tools and support to meet their strategic goals and navigate an increasingly complex sustainability landscape with confidence. As part of the agreement, Diligent will transition its carbon accounting clients to Persefoni’s market-leading platform and take an equity position in Persefoni, reinforcing a long-term commitment to innovation in ESG. This partnership ensures Diligent clients benefit from best-in-class capabilities in carbon footprint management, including advanced Scope 3 supply chain sustainability solutions and AI-powered disclosure readiness. "Diligent is committed to providing our customers with the best solutions available to meet today’s needs while preparing for tomorr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom